Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3317.00x is in line with its 1-year average of -3386.00x, near the high end of its 1-year range (-3455.00x–-3317.00x).
As of the fiscal period ended Friday, December 31, 2021.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-3317.00x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 453 covered companies
CURRENT VS SECTOR MEDIAN
-58712.06%
vs the sector median at left
OmniAb, Inc.
Market Cap
$642.23M
Interest Coverage Ratio
-3317.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$644.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$625.84M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$640.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$670.50M
Interest Coverage Ratio
35.83x
TTM Avg
47.17x
3Y Avg
33.36x
5Y Avg
33.36x
Market Cap
$610.22M
Interest Coverage Ratio
-133.54x
TTM Avg
0.30x
3Y Avg
1.45x
5Y Avg
7.08x
Market Cap
$674.89M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $642.23M | -3317.00x | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $644.25M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $636.74M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $625.84M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $640.87M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $670.50M | 35.83x | 47.17x | 33.36x | 33.36x |
| AngioDynamics, Inc. (ANGO)vs › | $610.22M | -133.54x | 0.30x | 1.45x | 7.08x |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $674.89M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $680.77M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $682.44M | N/A | N/A | N/A | N/A |
Interest Coverage
-3317.0x
Debt/Equity
0.07
Current Ratio
4.80
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -3317.00x |
| 2021-03-31 | -3455.00x |
